Perrigo Co PLC (NYSE: PRGO) Q1 2023 Earnings Call dated May. 09, 2023. Corporate Participants: Bradley Joseph -- Vice President of Investor
Perrigo Co PLC (PRGO) Q1 2023 Earnings Call Transcript

Perrigo Co PLC (NYSE: PRGO) Q1 2023 Earnings Call dated May. 09, 2023. Corporate Participants: Bradley Joseph -- Vice President of Investor
HEXO Corp (NYSE: HEXO) Q2 2023 earnings call dated Mar. 17, 2023 Corporate Participants: Charlie Bowman -- President and Chief Executive Officer Julius Ivancsits -- Chief
Cipher Pharmaceuticals Inc (TSE: CPH) Q4 2022 earnings call dated Mar. 17, 2023 Corporate Participants: Craig Mull -- Interim Chief Executive Officer Bryan Jacobs -- Chief
Canopy Growth Corporation (TSE: WEED) Q3 2023 earnings call dated Feb. 09, 2023 Corporate Participants: Tyler Burns -- Director, Investor Relations David Klein -- Chief Executive
Organigram Holdings Inc. (NASDAQ: OGI) Q1 2023 earnings call dated Jan. 12, 2023 Corporate Participants: Craig MacPhail -- Group Director Beena Goldenberg -- Chief Executive Officer
Tilray Inc (NASDAQ: TLRY) Q2 2023 earnings call dated Jan. 09, 2023 Corporate Participants: Berrin Noorata -- Chief Corporate Affairs Officer Irwin Simon -- Chairman and
Organigram Holdings Inc. (NASDAQ: OGI) Q4 2022 earnings call dated Nov. 29, 2022 Corporate Participants: Craig MacPhail -- Group Director, NATIONAL Capital Markets Beena
CRESCO LABS INC-SUBORDINATE (PNK: CL) Q2 2022 earnings call dated Aug. 17, 2022 Corporate Participants: Megan Kulick -- Senior Vice President - Investor Relations
Cipher Pharmaceuticals Inc. ( TSE: CPH) Q2 2022 earnings call dated Aug. 12, 2022 Corporate Participants: Craig Mull -- Interim Chief Executive Officer Scott
Cipher Pharmaceuticals Inc. (TSE: CPH) Q2 2022 earnings call dated Aug. 12, 2022 Corporate Participants: Craig Mull -- Interim Chief Executive Officer Scott Langille -- Chief
Perrigo Co PLC (NYSE: PRGO) Q2 2022 earnings call dated Aug. 09, 2022 Corporate Participants: Bradley Joseph -- Vice President, Global Investor Relations and
PetIQ, Inc. (NASDAQ: PETQ) Q2 2022 earnings call dated Aug. 09, 2022 Corporate Participants: Katie Turner -- Investor Relations McCord Christensen -- Chief Executive Officer and
ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) Q2 2022 earnings call dated Aug. 08, 2022 Corporate Participants: Lisa M. Wilson -- Investor Relations Nikhil Lalwani -- President and
Canopy Growth Corporation (TSE : WEED) Q1 2023 earnings call dated Aug. 05, 2022 Corporate Participants: Tyler Burns -- Director of Investor Relations David
Zoetis Inc. (NYSE: ZTS) Q2 2022 earnings call dated Aug. 04, 2022 Corporate Participants: Steven Frank -- Vice President of Investor Relation Kristin C.
Tilray, Inc. (NASDAQ: TLRY) Q4 2022 earnings conference call dated Jul. 28, 2022 Corporate Participants: Berrin Noorata -- Chief Corporate Affairs Officer Irwin David
Organigram Holdings Inc. (NASDAQ: OGI) Q3 2022 earnings call dated Jul. 14, 2022 Corporate Participants: Craig MacPhail -- Group Director Beena Goldenberg -- Chief Executive Officer
Canopy Growth Corporation (TSE: WEED) Q4 2022 earnings call dated May. 27, 2022 Corporate Participants: Tyler Burns -- Director, Investor Relations David Klein -- Chief Executive
Organigram Holdings Inc. (NASDAQ: OGI) Q2 2022 earnings call dated Apr. 12, 2022 Corporate Participants: Craig MacPhail -- Group Director Beena Goldenberg -- Chief Executive Officer
Cresco Labs Inc. (NASDAQ: CL) Q4 2021 earnings call dated Mar. 23, 2022 Corporate Participants: Jake Graves -- Investor Relations Charles Bachtell -- Chief Executive Officer
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) Q4 2021 earnings call dated Feb. 17, 2022 Corporate Participants: Matt Roach -- Director of Investor Relations Thomas McCourt -- Chief Executive